Cite

HARVARD Citation

    Tepper, S. et al. (n.d.). Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet neurology. 16 (6), pp. 425-434. [Online]. 
  
Back to record